Research progress on the correlation of inflammation factor and primary dysmenorrhea

Abstract

Abstract: Primary dysmenorrheal, one of the most common gynaecological disorders, is greatly concerned due to its strong influence on the normal work and life. It has been widely studied in recent years, finding that inflammatory factors played an important role in the pathogenesis of primary dysmenorrhea. The aim of our work was to review the effect of inflammatory factor on primary dysmenorrheal and new progression in therapy.

Key words: primary dysmenorrhea, inflammation factor, dysmenorrhea mechanism

CLC Number:

R711.51

XIE Dan, JU Ming-qiao, CAO Peng, WANG Da-wei, YU Bo-yang. Research progress on the correlation of inflammation factor and primary dysmenorrhea[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(3): 346-350.

References

[1] Dawood MY. Primary dysmenorrheal: advances in pathogenesis and management[J]. Obstet Gynecol, 2006, 108 (2): 428-441.
[2] 乐杰. 妇产科学[M]. 7版. 北京: 人民卫生出版社, 2011: 318.
[3] 李亚洲, 佟继铭. 原发性痛经发病机制与治疗[J]. 承德医学院学报, 2011, 28 (2): 193-195.
[4] 钱之玉. 药理学[M]. 3版. 北京: 中国医药科技出版社, 2000: 327-339.
[5] 赵敏珍, 应延风. 环氧化酶和痛经相关性研究进展[J]. 现代中西医结合杂志, 2008, 17(23):3712-3713.
[6] 李晶.子宫腺肌病痛经机理的研究进展[J].中国现代医药杂志,2008,10 (1):121-122.
[7] 嵇波,任晓暄,赵雅芳,等.原发性痛经发病机制与防治研究述评[J].中国现代医学杂志,2008,18 (13):1856-1858.
[8] 于传鑫,李诵纭.实用妇产科学[M].2版.上海:复旦大学出版社,2006:132-142.
[9] Brown RE,Stevens DR,Haas HL.The physiology of brain histamine[J].Prog Neurobio,2001,63 (6):637-672.
[10] 高珍,崔征,寇俊萍.组胺H₁受体功能及调节机制研究进展[J].现代生物医学进展,2009,9 (19):3768-3771.
[11] Bytautiene E,Vedernikov YP,Saade GR,et al.Degranulation of uterine mast cell modifies contractility of isolated myometrium from pregnant women[J].Am J Obstet Gynecol,2004,191 (5):1705-1710.
[12] Ortiz MI,Ponce-Monter HA,Mora-Rodríguez JA,et al.Synergistic relaxing effect of the paracetamol and pyrilamine combination in isolated human myometrium[J].Eur J Obstet Gynecol Reprod Biol,2011,157 (1):22-26.
[13] Maintz L,Bieber T,Novak N.Histamine intolerance in clinical practice[J].Dtsch Arztebl, 2006,103 (51/52):3477-3483.
[14] Maintz L,Schwarzer V,Bieber T,et al.Effects of histamine and diamine oxidase activities on pregnancy:a critical review[J].Hum Reprod Update,2008,14 (5):485-495.
[15] 王娜,宋卓敏.痛经宁颗粒对原发性痛经患者血清性激素及组胺含量的影响[J].辽宁中医杂志,2011,38 (4):685-687.
[16] 李继俊.妇产科内分泌治疗学[M].2版.北京:人民军医出版社,2012:73-88.
[17] Yeh ML,Chen HH,So EC,et al.A study of serum malondialdehyde and interleukin-6 levels in young women with dysmenorrhea in Taiwan[J].Life Sci,2004,75 (6):669-673.
[18] 赵敏珍,应延风.原发性痛经患者与外周血白细胞介素相关性研究[J].中国妇幼保健,2011, 26 (2):190-191.
[19] Marchini M,Manfredi B,Tozzi L,et al.Mitogen-induced lymphocyte proliferation and peripheral blood mononuclear cell beta-endorphin concentrations in primary dysmenorrhoea[J].Hum Reprod,1995,10 (4):815-817.
[20] Durain D.Primary dysmenorrhea:assessment and management update[J].J Midwifery Womens Health,2004,49 (6):520-528.
[21] French L.Dysmenorrhea[J].Am Fam Physician,2005,71 (2):285-291.
[22] 熊亚莉.原发性痛经的治疗进展[J].医药导报,2011,30 (2):232-234.
[23] Morrison BW,Daniels SE,Kotey P,et al.Rofecoxib,a specific cyclooxygenase-2 inhibitor,in primary dysmenorrhea:a randomized controlled trial[J].Obstet Gynecol,1999,94 (4):504-508.
[24] Daniels SE,Talwalker S,Torri S,et al.Valdecoxib,a cyclooxygenase-2-specific inhibitor,is effective in treating primary dysmenorrheal[J].Obstet Gynecol,2002,100 (2):350-358.
[25] Daniels S,Robbins J,West CR,et al.Celecoxib in the treatment of primary dysmenorrhea:results from two randomized,double-blind,active- and placebo-controlled,crossover studies[J].Clin Ther,2009,31 (6):1192-1208.
[26] Bitner M,Kattenhorn J,Hatfield C,et al.Efficacy and tolerability of lumiracoxib in the treatment of primary dysmenorrhoea[J].Int J Clin Pract,2004,58 (4):340-345.
[27] 张红梅,刘玉兰,杨错.痛经的治疗[J].实用药物与临床,2004,7 (3):43-45.
[28] Griffiths V.Traditional Chinese medicine:a case of dysmenorrhoea[J].Aust J Holist Nurs, 2000,7 (1):42-43.
[29] 王娜,胡晓慧,宋卓敏.痛经宁颗粒对原发性痛经患者血清肥大细胞脱颗粒及血清皮质醇含量的影响[J].中华中医药杂志,2011,26 (2):360-363.
[30] 杨继军,孙立虹,佘延芬,等.隔物灸对寒湿凝滞型原发性痛经患者内皮素和一氧化氮含量的影响[J].针刺研究,2008,33 (6):409-412.
[31] 姚合梅,陈盼碧,黄小瑾,等.艾灸对痛经大鼠子宫组织内皮素和一氧化氮的影响[J].时珍国医国药,2011,22 (3):586-587.
[32] 肖璐,闫宏宇.宁心缓痛汤对寒凝血瘀型原发性痛经大鼠子宫一氧化氮和钙离子的影响[J].新疆中医药,2011,29 (1):10-11.
[33] 吴宜艳,苏云明,邹辉,等.痛经舒口服液对模型小鼠血清及组织中GSH-PX和NO的影响[J].中医药学报,2007,35 (4):26-27.
[34] 党海珍,滕久祥,彭芝配,等.九气拈痛胶囊对痛经大鼠子宫组织内皮素和一氧化氮影响的实验研究[J].中国中医药科技,2001,8 (3):150-152.
[35] Fujiwara H,Konno R,Netsu S,et al.Efficacy of montelukast,a leukotriene receptor antagonist,for the treatment of dysmenorrhea:a prospective,double-blind,randomized,placebo-controlled study[J].Eur J Obstet Gynecol Reprod Biol,2010,148 (2):195-198.
[36] Harel Z,Riggs S,Vaz R,et al.The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents[J].J Pediatr Adolesc Gynecol,2004,17 (3):183-186.